PerkinElmer completed the acquisition of Project Farma.

PerkinElmer, a provider of analytical solutions and specialized services for biopharma, applied and food markets, completed the acquisition of Project Farma, a pharmaceutical company. Financial terms were not disclosed. "We are excited to welcome Project Farma’s highly skilled teams to PerkinElmer. This acquisition expands the professional services offering of OneSource, our market-leading lab solutions business, and creates an even stronger solution offering for life sciences customers throughout the value chain. The addition further accelerates our mission to empower customers in delivering innovative therapies to market with greater speed and efficiency," Dirk Bontridder, PerkinElmer CEO.